News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Troy Jackson accepted the Democratic Senate nomination in Maine, creating a competitive race against Sen. Susan Collins with potential Senate control implications.
  • Michigan reports over 8,100 cyclospora cases amid federal funding cuts and lab shortages, complicating outbreak containment and food-supply tracing.
  • Nationwide student protests in India over leaked NEET exam papers forced a retake and prompted the education minister's resignation amid reports of student deaths.
  • Israeli forces detained dozens in a West Bank village after a deadly clash that killed multiple Palestinians and two Israeli soldiers, with raids ongoing.
  • UNESCO placed Sebastia on the World Heritage and danger lists, escalating Palestinian claims and prompting Israeli rejection over West Bank land control.
  • Analysts highlighted memory and hardware opportunities: Citi reaffirmed buys on Samsung and SK Hynix, and trade ideas pitched Medtronic, Hesai, Reddit, and Charter.

Latest Articles

CECO Environmental and Thermon Group Holdings Announce that their respective Stockholders Approved the Strategic Combination and Provide Update on Election Results

CECO Environmental and Thermon Group Holdings Announce that their respective Stockholders Approved the Strategic Combination and Provide Update on Election Results

CECO Environmental Corp. and Thermon Group Holdings announced that their stockholders have overwhelmingly approved the strategic combination between the two companies, with over 99% votes in favor at their respective meetings. The transaction, expected to close around June 1, 2026, will combine CECO's environmental and industrial process solutions …

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

CRISPR Therapeutics AG, a leader in gene editing therapies and pioneer in CRISPR/Cas9 technology, announced its senior management will participate in key investor conferences in June 2026, including Jefferies, William Blair, and Goldman Sachs events. The company highlighted its recent FDA approval of CASGEVY®, the first CRISPR-based therapy for sic…

Aveanna Healthcare Announces Successful Debt Repricing

Aveanna Healthcare Announces Successful Debt Repricing

Aveanna Healthcare Holdings Inc. announced a successful repricing of its first lien and revolving credit facilities, resulting in a 50 basis point reduction in interest margins, with potential for an additional 25 basis point reduction upon credit rating upgrades. This refinancing move strengthens Aveanna's balance sheet and supports ongoing strate…

CPS Technologies Corp. Announces Pricing of $9.6 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

CPS Technologies Corp. Announces Pricing of $9.6 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

CPS Technologies Corp. has priced a registered direct offering of 1.2 million common shares at $8.00 per share, raising approximately $9.6 million before expenses. The proceeds will be used for general corporate purposes including working capital, capital expenditures, and commercialization of developing technologies. The offering is conducted unde…

BioCardia Announces Japan PMDA Record Of Advice Supports Regulatory Submission For Approval Of CardiAMP Cell Therapy For Ischemic Heart Failure

BioCardia Announces Japan PMDA Record Of Advice Supports Regulatory Submission For Approval Of CardiAMP Cell Therapy For Ischemic Heart Failure

BioCardia, Inc. announced that Japan's PMDA has issued a Consultation Record supporting the regulatory submission of CardiAMP Cell Therapy for ischemic heart failure with reduced ejection fraction (HFrEF). This follows successful clinical trials and confirms alignment on remaining questions ahead of submission. BioCardia plans to submit its applica…

PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval

PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval

PROCEPT BioRobotics announced the completion of enrollment for the randomized WATER IV study comparing Aquablation therapy to radical prostatectomy, and obtained FDA IDE approval for a second randomized study evaluating Aquablation therapy versus active surveillance in prostate cancer patients. Both studies aim to assess long-term disease control a…

Systemic immune activation with eftilagimod alfa associated with statistically significant increased overall survival in late-stage cancer patients

Systemic immune activation with eftilagimod alfa associated with statistically significant increased overall survival in late-stage cancer patients

Immutep Limited announced positive clinical data from an analysis of five trials showing that eftilagimod alfa (efti), an antigen-presenting cell activator, combined with standard-of-care therapies, significantly improves overall survival in late-stage cancer patients. The data indicate immune activation correlates with clinical benefit across vari…

ZenaTech Enters the AI Data Center Construction Market with ZenaWorx, a Drone-based 3D Digital Progress Monitoring Software

ZenaTech Enters the AI Data Center Construction Market with ZenaWorx, a Drone-based 3D Digital Progress Monitoring Software

ZenaTech, Inc. announces the development of ZenaWorx, a LiDAR-based Virtual Design and Construction progress monitoring software designed to enhance accuracy and reduce costs in AI data center construction. The software integrates drone-captured data analytics to provide precise 3D digital maps for tracking construction progress and deviations. A p…

Eli Lilly Shares Tick Higher After CVS Adds Zepbound to Preferred List

Eli Lilly Shares Tick Higher After CVS Adds Zepbound to Preferred List

Eli Lilly shares rose about 1% in pre-market trading after CVS Caremark said it would place Zepbound on its preferred drug list and expand coverage for Lilly’s obesity medicines. The change makes Lilly’s full obesity portfolio accessible through the nation’s three largest pharmacy benefit managers, with staged implementation dates and specific cost…

UBS Opens Coverage of Centiel With Neutral Rating, Says Growth Is Priced In

UBS Opens Coverage of Centiel With Neutral Rating, Says Growth Is Priced In

UBS initiated coverage of Swiss uninterruptible power supply maker Centiel AG with a "neutral" rating and a 12-month target price of CHF5.50, saying the stock already reflects the company's medium-term growth profile. The bank modeled organic sales CAGR of about 22% for FY25-28E and sees data centers as a key growth driver, but a reverse discounted…

Sidus Space Plunges After $100M Registered Direct Offering Priced at $5.08

Sidus Space Plunges After $100M Registered Direct Offering Priced at $5.08

Sidus Space shares tumbled 21% after the company announced a $100 million registered direct offering of Class A common stock and pre-funded warrants priced at $5.08 per unit. The company said net proceeds will be used for working capital and general corporate purposes; the offering, managed by ThinkEquity, is expected to close on May 29, 2026, subj…

Pope Leo Rejects Centuries-Old 'Just War' Framework, Calls for New Pathways to Peace

Pope Leo Rejects Centuries-Old 'Just War' Framework, Calls for New Pathways to Peace

Pope Leo's newly released encyclical repudiates the just war tradition long used to evaluate the morality of armed conflict, urging reliance on dialogue, diplomacy and forgiveness instead. The document, issued Monday, also calls for international oversight of artificial intelligence and includes a clear apology for the Catholic Church's historical …

U.S. Futures Slip Ahead of Inflation Print; HP Dips, Drone Stocks Advance

U.S. Futures Slip Ahead of Inflation Print; HP Dips, Drone Stocks Advance

U.S. stock futures opened lower as renewed strikes in the Gulf undermined prospects for a U.S.-Iran peace agreement and market participants prepared for a major inflation release that is closely followed by the Federal Reserve. By 06:37 ET (10:37 GMT), Dow futures were down about 60 points, S&P 500 futures fell roughly 14 points and Nasdaq 100 futu…

Rocket One’s Rebrand to AI-and-Space Focus Sends Shares Soaring

Rocket One’s Rebrand to AI-and-Space Focus Sends Shares Soaring

Shares of the company formerly known as Hoth Therapeutics surged in premarket trading as it began trading under the Rocket One name and new ticker, after announcing a corporate overhaul to pursue AI infrastructure, semiconductors and space-based AI systems for satellites. The firm has no recorded revenue and reported a loss of $0.17 per share in th…

BlackBerry's QNX: Positioning to Be the OS of Physical AI

BlackBerry's QNX: Positioning to Be the OS of Physical AI

BlackBerry's QNX has real traction as an embedded OS for regulated edge AI - partnerships with Nvidia and recent automotive wins give the company a path to meaningfully higher software annuity revenue. The stock looks expensive on trailing multiples today, but a combination of backlog conversion, higher gross margins and recurring SaaS-like revenue…

Kohl’s Maintains Full-Year Targets as Early Turnaround Moves Show Traction

Kohl’s Maintains Full-Year Targets as Early Turnaround Moves Show Traction

Kohl’s has reiterated its full-year guidance after reporting first-quarter net sales in line with estimates. Management highlighted cost reductions and merchandising changes - including lower-priced fresh items, a renewed focus on jewelry and accessories, and growth of its Sephora partnership - as drivers helping to stabilize performance. The compa…